110 related articles for article (PubMed ID: 32895480)
1. Correction: FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.
Wang K; Ji W; Yu Y; Li Z; Niu X; Xia W; Lu S
Oncogene; 2020 Oct; 39(42):6619-6620. PubMed ID: 32895480
[TBL] [Abstract][Full Text] [Related]
2. FGFR1-ERK1/2-SOX2 axis promotes cell proliferation, epithelial-mesenchymal transition, and metastasis in FGFR1-amplified lung cancer.
Wang K; Ji W; Yu Y; Li Z; Niu X; Xia W; Lu S
Oncogene; 2018 Sep; 37(39):5340-5354. PubMed ID: 29858603
[TBL] [Abstract][Full Text] [Related]
3. FGF1-FGFR1 axis promotes tongue squamous cell carcinoma (TSCC) metastasis through epithelial-mesenchymal transition (EMT).
Jiao J; Zhao X; Liang Y; Tang D; Pan C
Biochem Biophys Res Commun; 2015 Oct; 466(3):327-32. PubMed ID: 26362179
[TBL] [Abstract][Full Text] [Related]
4. Author Correction: Overexpression of Aiolos promotes epithelial-mesenchymal transition and cancer stem cell-like properties in lung cancer cells.
Hung JJ; Kao YS; Huang CH; Hsu WH
Sci Rep; 2020 Jan; 10(1):1309. PubMed ID: 31974483
[TBL] [Abstract][Full Text] [Related]
5. Author Correction: Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma.
Chen J; Ji T; Wu D; Jiang S; Zhao J; Lin H; Cai X
Cell Death Dis; 2019 Jun; 10(7):488. PubMed ID: 31221997
[TBL] [Abstract][Full Text] [Related]
6. Author Correction: Chronic IL-1β-induced inflammation regulates epithelial-to-mesenchymal transition memory phenotypes via epigenetic modifications in non-small cell lung cancer.
Li R; Ong SL; Tran LM; Jing Z; Liu B; Park SJ; Huang ZL; Walser TC; Heinrich EL; Lee G; Salehi-Rad R; Crosson WP; Pagano PC; Paul MK; Xu S; Herschman H; Krysan K; Dubinett S
Sci Rep; 2020 Mar; 10(1):4386. PubMed ID: 32127587
[TBL] [Abstract][Full Text] [Related]
7. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
[TBL] [Abstract][Full Text] [Related]
8. A Versatile Tumor Gene Deletion System Reveals a Crucial Role for FGFR1 in Breast Cancer Metastasis.
Wang W; Meng Y; Dong B; Dong J; Ittmann MM; Creighton CJ; Lu Y; Zhang H; Shen T; Wang J; Rowley DR; Li Y; Chen F; Moore DD; Yang F
Neoplasia; 2017 May; 19(5):421-428. PubMed ID: 28433771
[TBL] [Abstract][Full Text] [Related]
9. FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway.
Ji W; Yu Y; Li Z; Wang G; Li F; Xia W; Lu S
Oncotarget; 2016 Mar; 7(12):15118-34. PubMed ID: 26936993
[TBL] [Abstract][Full Text] [Related]
10. Author Correction: Interleukin-6/STAT3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells.
Gyamfi J; Lee YH; Eom M; Choi J
Sci Rep; 2020 Jul; 10(1):13049. PubMed ID: 32724090
[TBL] [Abstract][Full Text] [Related]
11. Correction: Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer.
Shin SB; Jang HR; Xu R; Won JY; Yim H
Oncogene; 2020 Jan; 39(4):951. PubMed ID: 31595031
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of
Shimizu D; Saito T; Ito S; Masuda T; Kurashige J; Kuroda Y; Eguchi H; Kodera Y; Mimori K
Cancer Genomics Proteomics; 2018; 15(4):313-320. PubMed ID: 29976636
[TBL] [Abstract][Full Text] [Related]
13. Correction: miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via downregulating histone H4K20 trimethylation through directly targeting SUV420H2.
Wu Y; Shi W; Tang T; Wang Y; Yin X; Chen Y; Zhang Y; Xing Y; Shen Y; Xia T; Guo C; Pan Y; Jin L
Cell Death Dis; 2019 Nov; 10(11):856. PubMed ID: 31719521
[TBL] [Abstract][Full Text] [Related]
14. Author Correction: A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1α activation, tumorigenesis and metastasis.
Rezaeian AH; Li CF; Wu CY; Zhang X; Delacerda J; You MJ; Han F; Cai Z; Jeong YS; Jin G; Phan L; Chou PC; Lee MH; Hung MC; Sarbassov D; Lin HK
Nat Cell Biol; 2020 Jul; 22(7):907. PubMed ID: 32504031
[TBL] [Abstract][Full Text] [Related]
15. Correction to: Heat Shock Protein 90 Stimulates Rat Mesenchymal Stem Cell Migration via PI3K/Akt and ERK1/2 Pathways.
Gao F; Hu X; Xie X; Liu X; Wang J
Cell Biochem Biophys; 2019 Sep; 77(3):273. PubMed ID: 31203503
[TBL] [Abstract][Full Text] [Related]
16. Correction: Baicalein inhibits fibronectin-induced epithelial-mesenchymal transition by decreasing activation and upregulation of calpain-2.
Chen Y; Chen L; Hong D; Chen Z; Zhang J; Fu L; Pan D; Zhang Y; Xu Y; Gan S; Xiao C; Tao L; Shen X
Cell Death Dis; 2020 Jul; 11(7):532. PubMed ID: 32661224
[TBL] [Abstract][Full Text] [Related]
17. Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
Zhangyuan G; Wang F; Zhang H; Jiang R; Tao X; Yu D; Jin K; Yu W; Liu Y; Yin Y; Shen J; Xu Q; Zhang W; Sun B
Oncogene; 2020 Feb; 39(6):1388. PubMed ID: 31700153
[TBL] [Abstract][Full Text] [Related]
18. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B
Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of SOX2 may be targeted by miR-590-5p and inhibits epithelial-to-mesenchymal transition in non-small-cell lung cancer.
Chang Z
Exp Ther Med; 2019 Aug; 18(2):1189-1195. PubMed ID: 31316613
[TBL] [Abstract][Full Text] [Related]
20. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
